J Vet Sci.  2008 Mar;9(1):103-107. 10.4142/jvs.2008.9.1.103.

Laparoscopy vs. laparotomy for embryo transfer to produce transgenic goats (Capra hircus)

Affiliations
  • 1College of Veterinary Medicine, Chungnam National University, Daejeon 305-764, Korea. stshin@cnu.ac.kr
  • 2Hanmi Research Center, Hwaseong 445-813, Korea.

Abstract

This study was performed to produce transgenic Korean native goat (Capra hircus) by laparoscopic embryo transfer (ET) to overcome the limitations of ET performed by laparotomy. Transgenic embryos were produced by DNA pronuclear microinjection of in vivo zygotes. The recipient goats were synchronized for estrus by using an introvaginal progesterone devices as a controlled internal drugreleasing insert (CIDR) for 13 days and injection of 400 IU PMSG 48 h before removal of the insert. Embryos were transferred on day 3 and 4 after removal of the insert. Recipient goats were deprived of feed for 48 h, then suspended in a laparotomy cradle at an angle of 45degrees. After obtaining a sufficient pneumoperitoneum, the laparoscope and forceps were inserted abdominally through 5 mm trocar sleeves. Examination of the ovaries and uterus was performed and then 213 embryos were transferred into the oviducts via the infundibula of 76 recipient goats. To compare pregnancy rates, ET was also performed by laparotomy in 82 recipient goats. The pregnancies in the recipient goats were diagnosed by ultrasound on day 30 after embryo transfer. The pregnancy rate with laparoscopic ET was significantly higher than with ET performed by laparotomy (46.1% vs. 28.6%, p < 0.05). In addition, the pregnancy rates were compared between ovulated and non-ovulated ovaries of the recipient goats in the laparoscopic ET group. No significant difference was observed between the pregnancy rates of ovulated and non-ovulated ovaries (41.3% vs. 33.3%, p < 0.05) suggesting that ET may also be possible in non-ovulated recipients through artificial rupture of Graafian follicles. These results suggest that laparoscopic ET is a highly efficient method for the transfer of goat embryos.

Keyword

embryo transfer; goat; laparoscopy; laparotomy; transgenic

MeSH Terms

Animals
Animals, Genetically Modified/*embryology
Embryo Transfer/methods/*veterinary
Female
Goats/*genetics/physiology
Laparoscopy/*veterinary
Laparotomy/*veterinary
Microinjections/veterinary
Oocytes

Figure

  • Fig. 1 Injection set for laparoscopic embryo transfer and embryo loading. (A) 5-cm polyethylene tube (1), injection needle (2) and 1-ml syringe (3). (B) Embryo loading in the injection needle.

  • Fig. 2 Laparoscopic embryo transfer. (A) Infundibulum was grasped with assist forceps, and then inserted into a polyethylene tube. (B) Insertion of polyethylene tube into the ampulla via the infundibulum. (C) Swollen oviduct after embryo transfer. (D) Preventing back flow of medium into the abdominal cavity by grasping the infundibulum with assist forceps.


Reference

1. Baldassarre H, Wang B, Kafidi N, Keefer C, Lazaris A, Karatzas CN. Advances in the production and propagation of transgenic goats using laparoscopic ovum pick-up and in vitro embryo production technologies. Theriogenology. 2002. 57:275–284.
Article
2. Baldassarre H, Wang B, Kafidi N, Gauthier M, Neveu N, Lapointe J, Sneek L, Leduc M, Duguay F, Zhou JF, Lazaris A, Karatzas CN. Production of transgenic goats by pronuclear microinjection of in vitro produced zygotes derived from oocytes recovered by laparoscopy. Theriogenology. 2003. 59:831–839.
Article
3. Besenfelder U, Mödl J, Müller M, Brem G. Endoscopic embryo collection and embryo transfer into the oviduct and the uterus of pigs. Theriogenology. 1997. 47:1051–1060.
Article
4. Clark AJ. The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins. J Mammary Gland Biol Neoplasia. 1998. 3:337–350.
5. Colman A. Production of proteins in the milk of transgenic livestock: problems, solutions, and successes. Am J Clin Nutr. 1996. 63:639S–645S.
Article
6. Denman J, Hayes M, O'Day C, Edmunds T, Bartlett C, Hirani S, Ebert KM, Gordon K, McPherson JM. Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: purification and characterization of the recombinant enzyme. Biotechnology. 1991. 9:839–843.
Article
7. Ebert KM, Selgrath JP, DiTullio P, Denman J, Smith TE, Memon MA, Schindler JE, Monastersky GM, Vitale JA, Gordon K. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression. Biotechnology. 1991. 9:835–838.
Article
8. Ebert KM, Schindler JES. Transgenic farm animals: progress report. Theriogenology. 1993. 39:121–135.
Article
9. Ebert KM, DiTullio P, Barry CA, Schindler JE, Ayres SL, Smith TE, Pellerin LJ, Meade HM, Denman J, Roberts B. Induction of human tissue plasminogen activator in the mammary gland of transgenic goats. Biotechnology. 1994. 12:699–702.
Article
10. Edmunds T, Van Patten SM, Pollock J, Hanson E, Bernasconi R, Higgins E, Manavalan P, Ziomek C, Meade H, McPherson JM, Cole ES. Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. Blood. 1998. 91:4561–4571.
Article
11. Gootwine E, Barash I, Bor A, Dekel I, Friedler A, Heller M, Zaharoni U, Zenue A, Shani M. Factors affecting success of embryo collection and transfer in a transgenic goat program. Theriogenology. 1997. 48:485–499.
Article
12. Fayrer-Hosken RA, Younis AI, Brackett BG, McBride CE, Harper KM, Keefer CL, Cabaniss DC. Laparoscopic oviductal transfer of in vitro matured and in vitro fertilized bovine oocytes. Theriogenology. 1989. 32:413–420.
Article
13. Houdebine LM. Production of pharmaceutical proteins from transgenic animals. J Biotechnol. 1994. 34:269–287.
Article
14. Kiessling AA, Hughes WH, Blankevoort MR. Superovulation and embryo transfer in the dairy goat. J Am Vet Med Assoc. 1986. 188:829–832.
15. Ko JH, Lee CS, Kim KH, Pang MG, Koo JS, Fang N, Koo DB, Oh KB, Youn WS, Zheng GD, Park JS, Kim SJ, Han YM, Choi IY, Lim J, Shin ST, Jin SW, Lee KK, Yoo OJ. Production of biologically active human granulocyte colony stimulating factor in the milk of transgenic goat. Transgenic Res. 2000. 9:215–222.
16. Koeman J, Keefer CL, Baldassarre H, Downey BR. Developmental competence of prepubertal and adult goat oocytes cultured in semi-defined media following laparoscopic recovery. Theriogenology. 2003. 60:879–889.
Article
17. Kühholzer B, Müller S, Besenfelder U, Prokofiev MI, Ernst LK, Brem G. Laparoscopic recovery of pronuclear-stage goat embryos. Vet Rec. 1998. 142:40–42.
Article
18. Lee CS, Fang NZ, Koo DB, Lee YS, Zheng GD, Oh KB, Youn WS, Han YM, Kim SJ, Lim JH, Shin ST, Jin SW, Lee KS, Ko JH, Koo JS, Park CS, Yoo OJ, Lee KK. Embryo recovery and transfer for the production of transgenic goats from Korean native strain, Capra hircus aegagrus. Small Rumin Res. 2000. 37:57–63.
Article
19. McKelvey WA, Robinson JJ, Aitken RP. A simplified technique for the transfer of ovine embryos by laparoscopy. Vet Rec. 1985. 117:492–494.
Article
20. Mutiga ER, Baker AA. Transfer of sheep embryos through a laparoscope. Vet Rec. 1984. 114:401–402.
Article
21. Rudolph NS. Biopharmaceutical production in transgenic livestock. Trends Biotechnol. 1999. 17:367–374.
Article
22. Takahashi Y, First N. In vitro development of bovine one-cell embryos: Influence of glucose, lactate, pyruvate, amino acids and vitamins. Theriogenology. 1992. 37:963–978.
Article
23. Tittel A, Treutner KH, Titkova S, Ottinger A, Schumpelick V. New adhesion formation after laparoscopic and conventional adhesiolysis: a comparative study in the rabbit. Surg Endosc. 2001. 15:44–46.
Article
24. Wang B, Baldassarre H, Tao T, Gauthier M, Neveu N, Zhou JF, Leduc M, Duguay F, Bilodeau AS, Lazaris A, Keefer C, Karatzas CN. Transgenic goats produced by DNA pronuclear microinjection of in vitro derived zygotes. Mol Reprod Dev. 2002. 63:437–443.
Article
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr